Related Experiment Video
Updated: Feb 11, 2026

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease
Published on: July 18, 2019
[Pathophysiology of respiratory insufficiency in neuromuscular diseases]
1Pneumologische Abteilung Medizinischen Universitätsklinik, Inselspital, Bern.
Abstract:
In end stage neuromuscular disease respiratory muscle fatigue can lead to respiratory failure. There is no close correlation between the degree of peripheral muscle weakness and the weakness of the respiratory muscles. Early in the disease the maximum in- and expiratory pressures can be abnormal even though the results of spirometry are normal. Progressive weakness of the respiratory muscles results in a decrease in vital capacity and eventually in alveolar hypoventilation, especially during sleep. General muscle weakness and fatigue may be the reasons why sleep hypoventilation is often overlooked in its early stages. Dyspnea may be a early symptom but it is not unusual that alveolar hypoventilation remains undetected until complications ensue (Cor pulmonale, polycythemia, altered alertness).
More Related Videos
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
09:24Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
Published on: April 17, 2017
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors